• Home
  • About Us
    Our Approach Our Team Board
  • Pipeline
  • News
  • Honor
  • Careers
  • Collaboration
  • Investor Relations
    Disclosure Contact IR
  • Contact
中文 ENG
    • Home
    • About us
      • Our Approach
      • Our Team
      • Board
    • Pipeline
    • News
    • Honor
    • Careers
    • Collaboration
    • Investor Relations
      • Disclosure
      • Contact IR
    • Contact
    • CN

COMPANY NEWS

Category Company News Enterprise Honor
2020 12

30

TYK Medicines Completed the B Round of Financing and Accelerated the Promotion of the Tumor Pipeline

Discover More
2020 11

24

TYK Medicines Innovative Drug Project was Successfully Selected 2021 Provincial Key R&D Program (Merit-based Project)

Discover More
2020 10

21

TYK Medicines’ Innovative Drug Project was Successfully Selected to 2022 Zhejiang Province Key Technology Innovation Program

Discover More
2020 10

01

TYK Medicines’ Innovative Drug Project was Successfully Selected to 2020 the Third Batch of Science and Technology Planning Projects

Discover More
2020 08

31

Livzon Pharmaceuticals and TYK Medicines Enter a Multi-targeted Kinase Inhibitor Greater China Equity Deal

Discover More
2020 08

24

TYK Medicines Received the Second Clinical Approval This Year with High Efficiency

Discover More
<34567>
CN ENG
  • Home
  • About Us
  • Pipeline
  • News
  • Honor
  • Careers
  • Investors
  • Contact
Powered by SE

Copyright © 2019 浙江同源康 版权所有 浙ICP备19008464号